Floatz logo

25 assets in Epithelial Neoplasm

Therapeutic assets addressing Epithelial Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Pembrolizumab
Epithelial Neoplasm
Sheba Medical CenterP2B (60)
Abemaciclib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Adriamycin
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Brigatinib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Carboplatin
Epithelial Neoplasm
Wenjun ChengP2CCC (53)
Catequentinib
Epithelial Neoplasm
Wenjun ChengP2CCC (53)
Ceritinib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Cobimetinib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Colchicinum
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Etoposide
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Lenvatinib
Epithelial Neoplasm
Sheba Medical CenterP2CCC (53)
Neratinib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
NKT2152
Epithelial Neoplasm
NiKang Therapeutics, Inc.P2CCC (53)
Palbociclib
Epithelial Neoplasm
NiKang Therapeutics, Inc.P2CCC (53)
Ponatinib
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Selinexor
Epithelial Neoplasm
University Health Network, TorontoP2CCC (53)
Triadeno Vaccine
Epithelial Neoplasm
National Cancer Institute (NCI)P2CCC (52)
Azacytidine
Epithelial Neoplasm
National Cancer Institute (NCI)P1/2CCC (48)
Avzo-1418
Epithelial Neoplasm
Avenzo Therapeutics, Inc.P1/2CC (45)
Immunotherapic Bifunctional Fusion Protein Comprised Of A Fully Human Igg1 Monoclonal Antibody (Avelumab) Against Human Programmed Death-Ligand 1 (Pd-L1) Fused To The Soluble Extracellular Domain Of Transforming Growth Factor-.Beta. (Tgf-.Beta.) Receptor Ii, Which Acts As A Tgf-.Beta. Trap
Epithelial Neoplasm
National Cancer Institute (NCI)P1/2CC (44)
Nogapendekin Alfa Inbakicept
Epithelial Neoplasm
National Cancer Institute (NCI)P2CC (44)
ab-1015
Epithelial Neoplasm
Arsenal Biosciences, Inc.P1CC (43)
G 207
Epithelial Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Si-B001
Epithelial Neoplasm
Sichuan Baili Pharmaceutical Co., Ltd.P1CC (43)
Sasanlimab
Epithelial Neoplasm
NiKang Therapeutics, Inc.P2C (34)